Skip to main content
. 2020 Mar 24;2(2):73–90. doi: 10.36628/ijhf.2020.0002

Figure 1. Kaplan-Meier curves for key endpoints of the PARADIGM-HF trial. Data from reference 24 with permission.

Figure 1

CI = confidence interval; HR = hazard ratio; PARADIGM-HF = Prospective Comparison of angiotensin receptor-neprilysin inhibitor (ARNI) with angiotensin converting enzyme inhibitor (ACEI) to Determine Impact on Global Mortality and Morbidity in Heart Failure.